perio y Flashcards
Gracey Curettes 1/2, 3/4 used on the
U+L anterior teeth
Design and Purpose: Gracey curettes
GCurettes are … instruments with multiple ….. options
The design of these curettes aims to reduce …, to maintain…
This ergonomic feature->prevents ..during
GCurettes are double-ended instruments with multiple handle options. The design of these curettes aims to reduce wrist flexion, to maintain a neutral hand, wrist, and forearm position during use. This ergonomic feature->prevents carpal tunnel syndrome- removal of subgingival plaque, calculus, and root planing.
Gracey Curettes- These are used on the buccal and lingual portions of posterior teeth.
7/8 and 9/10
Gracey Curettes used on the mesial portions of posterior teeth.
Gracey …is a modification of the …with a more …. angled shank to access the mesial surfaces of posterior teeth allows for …
11/12 and 15/16:
Gracey 15/16 is a modification of the 11/12 with a more acutely angled shank to access the mesial surfaces of posterior teeth[md pm]. The angulation allows better adaptation and a more stable intraoral fulcrum.
Gracey Curette used on the distal portions of posterior teeth
13/14 and 17/18:
Gracey Curette used on the anterior teeth and premolars
5/6
Full Mouth Debridement (FMD) Protocol:
Timing:
tx Regimen:
Complete ScRP all pockets in two sessions (2 hours each) within 24 hours.
Subgingival irrigation with CHX 3x within 10 minutes after each ScRP session.
Rinse with CHX twice daily for two weeks 30sec.
Perform standard oral hygiene including tooth brushing, interdental cleaning, and tongue brushing 1min.
Quadrant Debridement Protocol:
Timing:
Oral Hygiene Regimen:
1-hour session of ScRP per quadrant, scheduled at 2-week intervals.
Same as FMD: toothbrushing, interdental cleaning, and tongue brushing, with CHX m/w.
Common Aspects of FMD and Quadrant Debridement Protocol:
OR differences
1 Chlorhexidine (CHX) Use: Important in both methods for controlling bacterial load, though detailed CHX use immediately following treatment is emphasized more in the FMD + subgingival pockets.
2 Oral Hygiene Practices: Both protocols stress the importance of comprehensive oral hygiene practices including toothbrushing, interdental cleaning, and tongue brushing.
Bacteriophages are viruses that can infect and kill only bacteria.
Bacteriophage (FnpΦ02) which specifically infects and kills Fusobacterium nucleatum was discovered. Based on your knowledge of periodontal microbiology and pathogenesis, describe how FnpΦ02 could be useful in the prevention of periodontitis.
1.Target Bacterium:
Fusobacterium nucleatum- key to maturation of biofilm by bridging early colonizers to late colonizers of plaque
2 Mechanism of Action:
Selectively lyses Fusobacterium nucleatum.
Disrupts biofilm architecture.
Preserves beneficial oral microbiome.
3 Benefits in Preventing Periodontitis:
Disruption of Biofilm Integrity + maturation
Reduction in host Inflammatory Response.
4 Application in Therapy:
i-Could be part of phage-embedded material.
ii-Administered locally in periodontal pockets for sustained release.
iii-Complements mechanical debridement and prevents recurrence.
5 Concerns include safety, specificity, and bacterial resistance. Requires clinical trials to address potential issues.
main players are members of red complex [… ppr YEAR] are strongly associated with …
(Socransky et al. 2002)
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia—> PERIODONTITIS
4x Indications for using systemic antibiotics as an adjunct to periodontal therapy include:
1 Severe periodontal tissue breakdown that is either localized or generalized, especially if it is disproportionate to the patient’s age, eg indicating rapidly progressing CAL or bone loss young adult.
2 Severe periodontal tissue breakdown that persists despite the patient maintaining good oral hygiene and a low plaque score.
3 generalized bleeding on probing (BoP), that persists despite good oral hygiene+low plaque score + recent non-surgical/surgical periodontal tx
4 Stage III/Iv especially if the patient has already lost teeth and exhibits severe clinical attachment loss (CAL).
4x Contraindications for using systemic antibiotics in periodontal therapy include:
1Allergies to specific antibiotics.
2 Concerns about interactions with other medications -eg tetracycline +warfarin-inc Bleeding
3 tx of periodontal abscess unless the patient exhibits a systemic response to the local infection, such as fatigue, fever, facial swelling, or lymph gland involvement.
4 Refusal of periodontal treatment, as systemic antibiotics should only be considered in addition to non-surgical periodontal therapy, not as a standalone treatment.
systemic antibiotics prescribed as an adjunct to periodontal therapy include 3x….
These antibiotics are used to combat the …
Tetracyclines (ie Doxycycline and Minocycline), Metronidazole, and Penicillins (mainly Amoxicillin). bacterial infections that contribute to periodontal disease.
MechanismsOf action
Tetracyclines:
Metronidazole:
Amoxicillin
Tetracyclines: They inhibit protein synthesis in bacteria;bacteriostatic +reduces the growth and multiplication of periodontal pathogens.
Have anti-collagenase properties, which help in reducing tissue destruction.
Metronidazole: This antibiotic is effective against anaerobic bacteria and works by causing DNA strand breakage and cell death; bactericidal in bacteria.
Penicillins (Amoxicillin): They work by inhibiting bacterial cell wall synthesis, leading to cell lysis and death; bactericidal.
Use of more than one antibiotic may be necessary since periodontal infections often contain a wide variety of bacteria. Common combination of antibiotic regime is:-
studies demonstrated the efficacy of adjunctive treatments in improving …. and …
Metronidazole (± Amoxicillin) 250 mg of each/ 3x/day for 8 days has been used most routinely-additive effect + against Aggregatibacter actinomycetemcomitans. [Newman and Carranza’s Clinical Periodontology, Chapter 13th edition]
tetracycline and bactericidal (e.g., amoxicillin) =not function well together. Thus, they are best given
serially rather than in combination.
clinical parameters + reducing the burden of periodontal pathogens.
Single Abx dosage : …mg..?/day..for… days
Amoxycillin ; Metronidazole
Azithromycin
if allergic to penicillin->
Metronidazole/Amoxycillin = 500 mg 3x/day- 8 days
Azithromycin 500 mg OD for 4 - 7 days
Clindamycin 300 mg 3x/day for 10 days //
Doxycycline or Minocycline 100 mg OD 21 days
Scaling is the process involving the removal of
Root Planing is the process involving the removal of
plaque, calculus, and stains from the supragingival and subgingival surfaces of the teeth.
- removal of cementum or surface dentin that is rough or impregnated with calculus, toxins, or microorganisms.
Benefits SRP
1Remove: microbial plaque and retentive factor -calculus.
2 Disrupt biofilm subgingival.
3 Delay re-population of pathogenic microbes.
Risk Factors are variables with … relationship to disease dvlpmt eg
Variables with a direct causal relationship to disease development (e.g., pathogenic bacteria;smoking,DM for periodontal disease).
Risk Indicators are Variables associated with a higher… of disease but not… eg
likelihood
proven causal (e.g., obesity,HIV/AIDS,alcohol, osteoporosis and periodontal disease).
Risk Determinants are Broad characteristics that influence… but not…
Broad characteristics that influence risk but are not direct causes (e.g., age, gender,race).
Mx of periodontitis pt stage iii
MOST IMPORTANT CARD!!!
Treatment sequence for periodontitis stages I to III is described as a stepwise approach with the following outline:-
1 Patient Education & tx Plan Agreement
Goal: Inform patients about diagnosis, causes, risk factors, and treatment options. Establish a personalized treatment plan aligned with patient preferences and health changes.
2 First Step of Therapy EFP: Behavioral Change & Biofilm Control
-Motivate effective supragingival dental biofilm removal through patient education, DM control/smoking cessation-Ramseier et al. (2020)] /stress mx.
3 Phase I Therapy (Cause-Related Non-Surgical SRP)
Focus: Professional Mechanical Plaque Removal (PMPR): Remove supra+ SUBgingival plaque and calculus, and address plaque-retentive factors-caries removal. DONE via subgingival instrumentation, especially in subgingival pockets aimed to reduce or eliminate Periopathogens.
Adjunctive Interventions: May include physical or chemical agents, host-modulating agents[not enough evidence-Subantimicrobial Dose Doxycycline ;NSaids/bisphophonate], subgingival locally delivered antimicrobials, or systemic antimicrobials[only in young adults-stg III]
Phase II Therapy: Addressing Non-Responsive Areas
Techniques deep- ≥6mm: Repeat subgingival instrumentation or escalate to surgical interventions for better access and treatment of complex periodontal structures.
Surgical Options: Access flap surgery, resective surgery, or regenerative period. surgery targeting intra-bony and furcation lesions.
Maintenance Phase: Supportive Periodontal Care
Objective: Maintain periodontal stability through ongoing preventive and therapeutic measures.
Frequency: Regular visits tailored to the patient’s periodontal status, typically every 3, 6, or 12 months, with sessions lasting 45-60 minutes. Monitor osteoporosis/dM etc
Personalized Care: Adjust treatment plans based on clinical findings and patient responses over time
HOW TO address the horizontal bone loss not responding to SCRP?
Furcation Treatment? which grade?and rationale
Bone Grafting: Consider regenerative techniques, such as bone grafts, to address the horizontal bone loss.
Furcation Treatment: For Grade 2 furcations, regenerative procedures or tunnel preparations might be indicated. Rationale: To reduce furcation involvement and stabilize affected molars.
Stage I Periodontitis:
severity Characterized by 1 interdental clinical attachment loss of 1 to 2 mm and 2 rdgphc bone loss of coronal 1/3 (<15%).
3 NO tooth loss.
complexity - 1 Max probing depth ≤4 mm and mostly mild horizontal bone loss.
generally ,-less complex tx+ non-surgical and aimed at controlling bacterial infection and halting progression of the disease. Good prognosis
Stage II Periodontitis:
severity : -Increased destruction with Interdental CAL of 3 to 4 mm and radiographic bone loss extending to the coronal third (15%-33%).
NO tooth loss
complexity - 1 max probing depth is ≤5 mm and mostly horizontal bone loss.
mx: tx may include deeper cleaning/RP and possibly local adjunctive therapies. Prognosis is good
Stage III Periodontitis:
Severe destruction with significant deep pockets ≥6 mm, ID CAL ≥5 mm, and Rdgphc bone loss extending to the middle third of the root.
1- 4 teeth lost.
Horizontal and vertical [≥3 mm] bone loss; Furcation involvement Class II or III + and moderate ridge defects.
Treatment complexity increases due to the possible need for surgical /regenerative interventions and management of tooth mobility. Prognosis is fair
Stage IV Periodontitis:
Severe destruction with significant deep pockets ≥6 mm, ID CAL ≥5 mm, and Rdgphc bone loss extending to the middle third of the root and beyond.
≥5 teeth lost. Horizontal and vertical bone loss; Furcation involvement Class II or III + and severe ridge defects.
Need for complex rehabilitation dt masticatory dysfx, 2* occl trauma dt Mobility G>2, bite collapse, drifting, flaring, <20 teeth remaining (10 opposing pairs)
Treatment complexity increases due to the possible need for surgical interventions, management of tooth mobility or even tooth loss and regenerative therapies, including augmentation for implants, may be required. Multi-specialty treatment is often necessary, and the prognosis is questionable for maintenance.
Grade IN PERIODONTAL classification
Grade A (slow rate of progression- no CAL/RBL over 5 yrs)%bone loss/age <0.25, Heavy biofilm deposits but low lvl of destruction
Grade B (moderate rate of progression <2mm CAL/RBL over 5 yrs) %bone loss/age 0.25-1.0, biofilm consistent with amt of destruction
Grade C (rapid rate of progression ≥2 mm CAL/RBL over 5 yrs) %bone loss/age: > 1.0= aggressive nature. Destruction exceeds
expectations given amt biofilm deposit indicate early onset/rapid progression.
Grade modifiers include risk factors such as Smoking and DM
Grade A- Non smoker; no DM
Grade B- <10 cigarettes/day; HbA1c <7.0% with DM
Grade C- ≥10 cigarettes/day; HbA1c ≥7.0% with DM